Recovery and Symptom Relief Following Percutaneous Ablation of Abdominal Wall Endometriosis
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 发起方
- Mayo Clinic
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Symptom severity due to abdominal wall endometriosis following ablation.
研究概览
简要总结
To determine the characteristics of recovery and symptom relief following ablation of abdominal wall endometriosis.
详细描述
The purpose of this study is to characterize the recovery and symptom relief following cryoablation of abdominal wall endometriosis. Patients undergoing clinically indicated ablation of abdominal wall endometriosis will receive an endometriosis-specific symptom survey (Endometriosis Health Profile - 30) prior to ablation and then at 3-, 6-, 12-, and 24-months following treatment. A 2 question survey related to pain at the treatment site will also be administered prior to ablation and then at 1-, 7-, and 30-days after ablation.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Undergoing ablation for abdominal wall endometriosis.
排除标准
- •Decline to participate in research.
结局指标
主要结局
Symptom severity due to abdominal wall endometriosis following ablation.
时间窗: Baseline and intermittently over 24 months
Using the Endometriosis Health Profile - 30 survey, the impact of ablation on endometriosis-related symptoms will be quantified over time. A numerical rating scale will be used to quantify pain at the site of treated abdominal wall endometriosis.
次要结局
未报告次要终点
研究者
Thomas D. Atwell
Principal Investigator
Mayo Clinic